Articles by Sven Meuth, MD, PhD
The Future of Treating Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Decision-Making Process for Treating Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Switching Therapies in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Role of Ozanimod in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Role of Diroximel Fumarate in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Role of Ocrelizumab in Europe for Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Ocrelizumab for the Treatment of Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Role of Siponimod in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Treating With Cladribine in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Clinical Trials for Cladribine in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
The Use of Glatiramer Acetate in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
The Use of Interferon in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
First-Line Therapies for Relapsing Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Clinically Isolated Syndrome Versus Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
MOG-IgG in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Differential Diagnosis of Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
Diagnosis of Multiple Sclerosis: The McDonald Criteria
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD
Clinical Trials for Cladribine in Multiple Sclerosis
The Use of Interferon in Multiple Sclerosis
Clinically Isolated Syndrome Versus Multiple Sclerosis
Role of Diroximel Fumarate in Multiple Sclerosis
Switching Therapies in Multiple Sclerosis
Role of Ozanimod in Multiple Sclerosis
